Boron neutron capture therapy of cancer: where do we stand now?

References

[1] Barth RF, Grecula JC. Boron neutron capture therapy at the crossroads -Where do we go from here? Appl Radiat Isot. 2020; 160: 109029.

[2] Barth RF, Zhang Z, Liu T. A realistic appraisal of boron neutron capture therapy as a cancer treatment modality. Cancer Commun (Lond). 2018; 38(1): 36.

[3] Barth RF, Gupta N, Kawabata S. Evaluation of Sodium Borocaptate (BSH) and Boronophenylalanin (BPA) as Boron Delivery Agents for Neutron Capture Therapy (NCT) of Cancer: An Update and a Guide for the Future Clinical Evaluation of New Boron Delivery Agents for NCT. Cancer Communications. 2024,

[4] Cheng X, Li F, Liang L. Boron Neutron Capture Therapy: Clinical Application and Research Progress. Curr Oncol. 2022; 29(10): 7868–7886.

[5] Oloo SO, Smith KM, Vicente M. Multi-Functional Boron-Delivery Agents for Boron Neutron Capture Therapy of Cancers. Cancers (Basel). 2023; 15(13): 3277.

[6] Wang LW, Liu YH, Chu PY, Liu HM, Peir JJ, Lin KH, et al. Boron Neutron Capture Therapy Followed by Image-Guided Intensity-Modulated Radiotherapy for Locally Recurrent Head and Neck Cancer: A Prospective Phase I/II Trial. Cancers (Basel). 2023; 15(10): 2762.

[7] Zhang Z, Chong Y, Liu Y, Pan J, Huang C, Sun Q, et al. A Review of Planned, Ongoing Clinical Studies and Recent Development of BNCT in Mainland of China. Cancers (Basel). 2023; 15(16): 4060.

[8] Elowitz EH, Bergland RM, Coderre JA, Joel DD, Chadha M, Chanana AD. Biodistribution of p-boronophenylalanine in patients with glioblastoma multiforme for use in boron neutron capture therapy. Neurosurgery. 1998; 42(3): 463–468; discussion 8-9.

[9] Goodman JH, Yang W, Barth RF, Gao Z, Boesel CP, Staubus AE, et al. Boron neutron capture therapy of brain tumors: biodistribution, pharmacokinetics, and radiation dosimetry sodium borocaptate in patients with gliomas. Neurosurgery. 2000; 47(3): 608–621; discussion 21-2.

[10] Barth RF, Mi P, Yang W. Boron delivery agents for neutron capture therapy of cancer. Cancer Commun (Lond). 2018; 38(1): 35.

[11] Kondo N, Hirano F, Temma T. Evaluation of 3-Borono-l-Phenylalanine as a Water-Soluble Boron Neutron Capture Therapy Agent. Pharmaceutics. 2022; 14(5): 1106.

[12] Nomoto T, Inoue Y, Yao Y, Suzuki M, Kanamori K, Takemoto H, et al. Poly(vinyl alcohol) boosting therapeutic potential of p-boronophenylalanine in neutron capture therapy by modulating metabolism. Sci Adv. 2020; 6(4): eaaz1722.

[13] Matsumura A, Asano T, Hirose K, Igaki H, Kawabata S, Kumada H. Initiatives Toward Clinical Boron Neutron Capture Therapy in Japan. Cancer Biother Radiopharm. 2023; 38(3): 201–207.

[14] Porra L, Wendland L, Seppala T, Koivunoro H, Revitzer H, Tervonen J, et al. From Nuclear Reactor-Based to Proton Accelerator-Based Therapy: The Finnish Boron Neutron Capture Therapy Experience. Cancer Biother Radiopharm. 2023; 38(3): 184–191.

[15] Zamenhof R, Redmond E, 2nd, Solares G, Katz D, Riley K, Kiger S, et al. Monte Carlo-based treatment planning for boron neutron capture therapy using custom designed models automatically generated from CT data. Int J Radiat Oncol Biol Phys. 1996; 35(2): 383–397.

[16] Sato M, Hirose K, Takeno S, Aihara T, Nihei K, Takai Y, et al. Safety of Boron Neutron Capture Therapy with Borofalan(10B) and Its Efficacy on Recurrent Head and Neck Cancer: Real-World Outcomes from Nationwide Post-Marketing Surveillance. Cancers. 2024; 16(5): 869.

[17] Takai S, Wanibuchi M, Kawabata S, Takeuchi K, Sakurai Y, Suzuki M, et al. Reactor-based boron neutron capture therapy for 44 cases of recurrent and refractory high-grade meningiomas with long-term follow-up. Neuro Oncol. 2022; 24(1): 90–98.

[18] Hiratsuka J, Kamitani N, Tanaka R, Tokiya R, Yoden E, Sakurai Y, et al. Long-term outcome of cutaneous melanoma patients treated with boron neutron capture therapy (BNCT). J Radiat Res. 2020; 61(6): 945–951.

[19] Hiratsuka J, Kamitani N, Tanaka R, Yoden E, Tokiya R, Suzuki M, et al. Boron neutron capture therapy for vulvar melanoma and genital extramammary Paget’s disease with curative responses. Cancer Commun (Lond). 2018; 38(1): 38.

[20] Taskaev S, Berendeev E, Bikchurina M, Bykov T, Kasatov D, Kolesnikov I, et al. Neutron Source Based on Vacuum Insulated Tandem Accelerator and Lithium Target. Biology (Basel). 2021; 10(5): 350.

RIGHTS & PERMISSIONS

2024 The Authors. Cancer Communications published by John Wiley & Sons Australia, Ltd. on behalf of Sun Yat-sen University Cancer Center.